Q1-2023 Dermatology Update
The dermatology space has shown to be resilient from macroeconomic conditions that have impacted M&A activity (rising cost of debt, tight credit markets) in other industries. Strategic acquirers, that have recently traded hands to larger private equity funds, have been the most active buyer cohort, accounting for most of the deal activity over the last few quarters. Provident expects M&A activity and valuation ranges to continue at current levels as debt markets eventually settle down.
To print and download the full Dermatology Update report, please click below…
